Find a Doctor - Search by last name or narrow your search by gender or languages spoken
Find a Location - Search by specialty, city, or state
Dr. John Pope reviews medical content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. Dr. Pope is a pediatrician in Phoenix, Arizona. He is Medical Director of Pediatric Inpatient and Hospitalist Services for the Scottsdale Healthcare Hospital System in Scottsdale, Arizona. He serves as a Clinical Assistant Professor at the Arizona College of Osteopathic Medicine in Glendale, Arizona, and at the University of Arizona College of Medicine in Phoenix, Arizona.
MD: Dartmouth Medical School, Hanover, NH, 1989
Internship in Pediatrics: Children’s Hospital of Philadelphia, Philadelphia, PA, 1989–1990
Residency in Pediatrics: Children's Hospital of Philadelphia, Philadelphia, PA, 1990–1992
MPH: University of Arizona, Mel and Enid Zuckerman School of Public Health, Tucson, AZ, 2005
Clinical Assistant Professor, University of Arizona Department of Pediatrics, College of Medicine, Phoenix, AZ, 2008–present
Clinical Assistant Professor, University of Arizona College of Osteopathic Medicine, Clinical Education, Phoenix, AZ, 2008–present
Adjunct Assistant Professor of Pediatrics, Dartmouth Medical School, Hanover, NH, 1995–1999
Clinical Instructor of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, 1992–1995
Last Revised: January 27, 2010
Author: Healthwise Staff
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
RT @drdavidpearce: Early trigger for #alzheimers http://t.co/aQnGFDHYnT reported might be a target for #neurodegenerative & #rarediseases